Cipla shares surged past ₹1,580–1,590 on strong volumes, with analyst Deepak Pal eyeing a rally toward ₹1,700–1,750 in the coming weeks. Indicators like MACD and RSI support the bullish trend, while USFDA approvals, robust Q1 growth, and sector tailwinds add strength. Support now lies at ₹1,500–1,520. Retail sentiment on Stocktwits remains 'neutral.'